Abstract
The proliferation and differentiation of cells is a highly regulated process that is controlled primarily at the level of the interaction of growth factors with their cell surface receptors. However, a variety of different retroviruses alter signal transduction pathways in infected cells, which is critical for the pathogenic process. Many studies have focused on how viral oncogenes and pathogenic genes associated with these retroviruses deregulate signal transduction pathways. Protein kinases, either encoded or activated by retroviruses, appear to play a major role. In this chapter, the effects of oncogenic retroviruses on signal transduction pathways will be reviewed for four oncogenic retroviruses: Abelson murine leukemia virus, S13 avian erythroblastosis virus, Friend spleen focus-forming virus, and Jaagsiekte sheep retrovirus. Each retrovirus uses a different mechanism to deregulate cell signaling.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Abelson, H. T., and Rabstein, L. S. 1970. Lymphosarcoma: virus-induced thymic-independent disease in mice. Cancer Res. 30:2213–2222.
Agazie, Y., Ischenko, I., and Hayman, M. 2002. Concomitant activation of the PI3K-Akt and the Ras-ERK signaling pathways is essential for transformation by the V-SEA tyrosine kinase oncogene. Oncogene 21:697–707.
Aizawa, S., Suda, Y., Furuta, Y., et al. 1990. Env-derived gp55 gene of Friend spleen focus-forming virus specifically induces neoplastic proliferation of erythroid progenitor cells. EMBO J. 9:2107–2116.
Alian, A., Sela-Donenfeld, D., Panet, A., et al. 2000. Avian hemangioma retrovirus induces cell proliferation via the envelope (env) gene. Virology 276:161–168.
Allen, T. E., Sherrill, K. J., Crispell, S. M., et al. 2002. The jaagsiekte sheep retrovirus envelope gene induces transformation of the avian fibroblast cell line DF-1 but does not require a conserved SH2 binding domain. J. Gen. Virol. 83:2733–2742.
Amanuma, H., Katori, A., Obata, M., et al. 1983. Complete nucleotide sequence of the gene for the specific glycoprotein (gp55) of Friend spleen focus-forming virus. Proc. Natl. Acad. Sci. U S A 80:3913–3917.
Amanuma, H., Watanabe, N., Nishi, M., et al. 1989. Requirement of the single base insertion at the 3 end of the env-related gene of Friend spleen focus-forming virus for pathogenic activity and its effect on localization of the glycoprotein product (gp55). J. Virol. 63:4824–4833.
Baker, S. J., Rane, S. G., et al. 2007. Hematopoietic cytokine receptor signaling. Oncogene 26:6724–6737.
Balduzzi, P. C., Notter, M. F., Morgan, H. R., et al. 1981. Some biological properties of two new avian sarcoma viruses. J. Virol. 40:268–275.
Banerjee, A., and Rothman, P. 1998. IL-7 reconstitutes multiple aspects of v-Abl-mediated signaling. J. Immunol. 161:4611–4467.
Barbacid, M., Lauver, A. V., and Devare, S. G. 1980. Biochemical and immunological characterization of polyproteins coded for by the McDonough, Gardner-Arnstein, and Snyder-Theilen strains of feline sarcoma virus. J. Virol. 33:196–207.
Baughn, L. B., and Rosenberg, N. 2005. Disruption of the Shc/Grb2 complex during abelson virus transformation affects proliferation, but not apoptosis. J. Virol. 79:2325–2334.
Bellacosa, A., Testa, J. R., Staal, S. P., et al. 1991. A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region. Science 254:274–277.
Ben David, Y., Prideaux, V. R., Chow, V., et al. 1988. Inactivation of the p53 oncogene by internal deletion or retroviral integration in erythroleukemic cell lines induced by Friend leukemia virus. Oncogene 3:179–185.
Besmer, P., Lader, E., George, P. C., et al. 1986a. A new acute transforming feline retrovirus with fms homology specifies a C-terminally truncated version of the c-fms protein that is different from SM-feline sarcoma virus v-fms protein. J. Virol. 60:194–203.
Besmer, P., Murphy, J. E., George, P. C., et al. 1986b. A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family. Nature 320:415–421.
Beug, H., Hayman, M. J., Graf, T., et al. 1985. S13, a rapidly oncogenic replication-defective avian retrovirus. Virology 145:141–153.
Bonne, C. 1939. Morphological resemblance of pulmonary adenomatosis (Jaagsiekte) in sheep and certain cases of cancer of the lung in man. Am. J. Cancer 35:491–501.
Boss, M., Greaves, M., and Teich, N. 1979. Abelson virus-transformed haematopoietic cell lines with pre-B-cell characteristics. Nature 278:551–553.
Bromberg, J. 2002. Stat proteins and oncogenesis. J. Clin. Invest. 109:1139–1142.
Burstein, H., Resnick-Roguel, N., Hamburger, J., et al. 1990. Unique sequences in the env gene of avian hemangioma retrovirus are responsible for cytotoxicity and endothelial cell perturbation. Virology 179:512–516.
Caporale, M., Cousens, C., Centorame, P., et al. 2006. Expression of the jaagsiekte sheep retrovirus envelope glycoprotein is sufficient to induce lung tumors in sheep. J. Virol. 80:8030–8037.
Casadevall, N., Lacombe, C., Muller, O., et al. 1991. Multimeric structure of the membrane erythropoietin receptor of murine erythroleukemia cells (Friend cells). Cross-linking of erythropoietin with the spleen focus-forming virus envelope protein. J. Biol. Chem. 266:16015–16020.
Chang, H. W., Aoki, M., Fruman, D., et al. 1997. Transformation of chicken cells by the gene encoding the catalytic subunit of PI 3-kinase. Science 276:1848–1850.
Chen, Q., Turner, J., Watson, A. J., et al. 1997. v-Abl protein tyrosine kinase (PTK) mediated suppression of apoptosis is associated with the up-regulation of Bcl-XL. Oncogene 15:2249–2254.
Chen, R., Kim, O., Yang, J., et al. 2001. Regulation of Akt/PKB activation by tyrosine phosphorylation. J. Biol. Chem. 276:31858–31862.
Chen, Y. Y., Wang, L. C., Huang, M. S., et al. 1994. An active v-abl protein tyrosine kinase blocks immunoglobulin light-chain gene rearrangement. Genes Dev. 8:688–697.
Chirigos, M. A., Scott, D., Turner, W., et al. 1968. Biological, pathological and physical characterization of a possible variant of a murine sarcoma virus (Moloney). Int. J. Cancer 3:223–227.
Chung, S. W., Wolff, L., and Ruscetti, S. K. 1989. Transmembrane domain of the envelope gene of a polycythemia-inducing retrovirus determines erythropoietin-independent growth. Proc. Natl. Acad. Sci. U S A 86:7957–7960.
Clark, S. P., and Mak, T. W. 1983. Complete nucleotide sequence of an infectious clone of Friend spleen focus-forming provirus: gp55 is an envelope fusion glycoprotein. Proc. Natl. Acad. Sci. U S A 80:5037–5041.
Cleveland, J. L., Dean, M., Rosenberg, N., et al. 1989. Tyrosine kinase oncogenes abrogate interleukin-3 dependence of murine myeloid cells through signaling pathways involving c-myc: conditional regulation of c-myc transcription by temperature-sensitive v-abl. Mol. Cell Biol. 9:5685–5695.
Collett, M. S., and Erikson, R. L. 1978. Protein kinase activity associated with the avian sarcoma virus src gene product. Proc. Natl. Acad. Sci. U S A 75:2021–2024.
Collett, M. S., Purchio, A. F., et al. 1980. Avian sarcoma virus-transforming protein, pp60src shows protein kinase activity specific for tyrosine. Nature 285:167–169.
Cong, F., Zou, X., Hinrichs, K., et al. 1999. Inhibition of v-Abl transformation by p53 and p19ARF. Oncogene 18:7731–7739.
Constantinescu, S. N., Wu, H., Liu, X., et al. 1998. The anemic Friend virus gp55 envelope protein induces erythroid differentiation in fetal liver colony-forming units-erythroid. Blood 91:1163–1172.
Constantinescu, S. N., Liu, X., Beyer, W., et al. 1999. Activation of the erythropoietin receptor by the gp55-P viral envelope protein is determined by a single amino acid in its transmembrane domain. EMBO J. 18:3334–3347.
Constantinescu, S. N., Keren, T., Russ, W. P., et al. 2003. The erythropoietin receptor transmembrane domain mediates complex formation with viral anemic and polycythemic gp55 proteins. J. Biol. Chem. 278:43755–43763.
Cook, W. D., Metcalf, D., Nicola, N. A., et al. 1985. Malignant transformation of a growth factor-dependent myeloid cell line by Abelson virus without evidence of an autocrine mechanism. Cell 41:677–683.
Cousens, C., Bishop, J. V., Philbey, A. W., Gill, C. A., Palmarini, M., Carlson, J. O., DeMartini, J. C., and Sharp, J. M. 2004. Analysis of integration sites of Jaagsiekte sheep retrovirus in ovine pulmonary adenocarcinoma. J. Virol. 78:8506–8512.
Cousens, C., Maeda, N., Murgia, C., et al. 2007. In vivo tumorigenesis by Jaagsiekte sheep retrovirus (JSRV) requires Y590 in Env TM, but not full-length orfX open reading frame. Virology 367:413–421.
Crowe, A. J., and Hayman, M. J. 1991. A myristylated form of the sea oncoprotein can transform chicken embryo fibroblasts. J. Virol. 65:2533–2538.
Crowe, A. J., and Hayman, M. J. 1993a. Post-translational modifications of the env-sea oncogene product: the role of proteolytic processing in transformation. Oncogene 8:181–189.
Crowe, A. J., and Hayman, M. J. 1993b. Altered glycosylation of the env-sea oncoprotein inhibits intracellular transport and transformation. Cell Growth Differ. 4:403–410.
Crowe, A. J., McGlade, J., Pawson, T., et al. 1994. Phosphorylation of the SHC proteins on tyrosine correlates with the transformation of fibroblasts and erythroblasts by the v-sea tyrosine kinase. Oncogene 9:537–544.
Dakessian, R. M., Inoshima, Y., and Fan, H. 2007. Tumors in mice transgenic for the envelope protein of Jaagsiekte sheep retrovirus. Virus Genes 35:73–80.
Danial, N. N., Pernis, A., and Rothman, P. B. 1995. Jak-STAT signaling induced by the v-abl oncogene. Science 269:1875–1877.
Danial, N. N., Losman, J. A., Lu, T., et al. 1998. Direct interaction of Jak1 and v-Abl is required for v-Abl-induced activation of STATs and proliferation. Mol. Cell Biol. 18:6795–6804.
Danilkovitch-Miagkova, A., Duh, F. M., Kuzmin, et al. 2003. Hyaluronidase 2 negatively regulates RON receptor tyrosine kinase and mediates transformation of epithelial cells by jaagsiekte sheep retrovirus. Proc. Natl. Acad. Sci. U S A 100:4580–4585.
Datta, S. R., Dudek, H., Tao, X., et al. 1997. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91:231–241.
De las Heras, M., Sharp, J. M., Garcia de Jalon, J. A., et al. 1991. Enzootic nasal tumour of goats: demonstration of a type D-related retrovirus in nasal fluids and tumours. J. Gen. Virol. 72(Pt 10):2533–2535.
De Las Heras, M., Ortin, A., Benito, A., et al. 2006. In-situ demonstration of mitogen-activated protein kinase Erk 1/2 signalling pathway in contagious respiratory tumours of sheep and goats. J. Comp. Pathol. 135:1–10.
DeMartini, J. C., Carlson, J. O., Leroux, C., et al. 2003. Endogenous retroviruses related to jaagsiekte sheep retrovirus. Curr. Top. Microbiol. Immunol. 275:117–137.
Dirks, C., Duh, F. M., Rai, S. K., et al. 2002. Mechanism of cell entry and transformation by enzootic nasal tumor virus. J. Virol. 76:2141–2149.
Doolittle, R. F., Hunkapiller, M. W., Hood, L. E., Devare, S. G., Robbins, K. C., Aaronson, S. A., and Antoniades, H. N. 1983. Simian sarcoma virus onc gene, v-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor. Science 221:275–277.
Downward, J., Yarden, Y., Mayes, E., et al. 1984. Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences. Nature 307:521–527.
Engelbreth-Holm, J., and Rothe-Meyer, A. 1935. On the connection between erythroblastosis (haemocytoblastosis), myelosis, and sarcoma in the chicken. Acta Pathol. Microbiol. Scand. 12:352–365.
Erman, M., Grunenwald, D., Penault-Llorca, F., et al. 2005. Epidermal growth factor receptor, HER-2/neu and related pathways in lung adenocarcinomas with bronchioloalveolar features. Lung Cancer 47:315–323.
Evans, C. A., Lord, J. M., Owen-Lynch, P. J., et al. 1995. Suppression of apoptosis by v-ABL protein tyrosine kinase is associated with nuclear translocation and activation of protein kinase C in an interleukin-3-dependent haemopoietic cell line. J. Cell Sci. 108(Pt 7):2591–2598.
Fang, C., Choi, E., Nie, L., et al. 1998. Role of the transmembrane sequence of spleen focus-forming virus gp55 in erythroleukemogenesis. Virology 252:46–53.
Feldman, R. A., Hanafusa, T., and Hanafusa, H. 1980. Characterization of protein kinase activity associated with the transforming gene product of Fujinami sarcoma virus. Cell 22:757–765.
Ferro, F. E., Jr., Kozak, S. L., Hoatlin, M. E., et al. 1993. Cell surface site for mitogenic interaction of erythropoietin receptors with the membrane glycoprotein encoded by Friend erythroleukemia virus. J. Biol. Chem. 268:5741–5747.
Finkelstein, L. D., Ney, P. A., Liu, Q. P., et al. 2002. Sf-Stk kinase activity and the Grb2 binding site are required for Epo-independent growth of primary erythroblasts infected with Friend virus. Oncogene 21:3562–3570.
Fisher, R. C., Slayton, W. B., Chien, C., et al. 2004. PU.1 supports proliferation of immature erythroid progenitors. Leuk. Res. 28:83–89.
Franz, W. M., Berger, P., and Wang, J. Y. 1989. Deletion of an N-terminal regulatory domain of the c-abl tyrosine kinase activates its oncogenic potential. EMBO J. 8:137–147.
Friend, C. 1957. Cell-Free Transmission in Adult Swiss Mice of a Disease Having the Character of a Leukemia. J. Exp. Med. 105:307–318.
Fujinami, A., and Inamoto, K. 1914. Ueber Gerwultse bei japanishen Haushuhnern insbesondere uber einen transplantablen Tumor. Z Krebsforsch 14:94–119.
Ghysdael, J., Neil, J. C., Wallbank, A. M., et al. 1981. Esh avian sarcoma virus codes for a gag-linked transformation-specific protein with an associated protein kinase activity. Virology 111:386–400.
Gliniak, B. C., and Kabat, D. 1989. Leukemogenic membrane glycoprotein encoded by Friend spleen focus-forming virus: transport to cell surfaces and shedding are controlled by disulfide-bonded dimerization and by cleavage of a hydrophobic membrane anchor. J. Virol. 63:3561–3568.
Goff, S. P., Gilboa, E., Witte, O. N., et al. 1980. Structure of the Abelson murine leukemia virus genome and the homologous cellular gene: studies with cloned viral DNA. Cell 22:777–785.
Gong, L., Unnikrishnan, I., Raghavan, A., et al. 2004. Active Akt and functional p53 modulate apoptosis in Abelson virus-transformed pre-B cells. J. Virol. 78:1636–1644.
Green, P. L., Kaehler, D. A. and Risser, R. 1987. Clonal dominance and progression in Abelson murine leukemia virus lymphomagenesis. J. Virol. 61:2192–2197.
Green, P. L., Kaehler, D. A., Bennett, L. M., et al. 1989. Multiple steps are required for the induction of tumors by Abelson murine leukemia virus. J. Virol. 63:1989–1994.
Halupa, A., Bailey, M. L., Huang, K., et al. 2005. A novel role for STAT1 in regulating murine erythropoiesis: deletion of STAT1 results in overall reduction of erythroid progenitors and alters their distribution. Blood 105:552–561.
Hampe, A., Laprevotte, I., Galibert, F., et al. 1982. Nucleotide sequences of feline retroviral oncogenes (v-fes) provide evidence for a family of tyrosine-specific protein kinase genes. Cell 30:775–785.
Harvey, J. J. 1964. An unidentified virus which causes the rapid production of tumours in mice. Nature 204:1104–1105.
Hayman, M. J., Kitchener, G., Vogt, P. K., et al. 1985. The putative transforming protein of S13 avian erythroblastosis virus is a transmembrane glycoprotein with an associated protein kinase activity. Proc. Natl. Acad. Sci. U S A 82:8237–8241.
Hoatlin, M. E., Kozak, S. L., Lilly, F., et al. 1990. Activation of erythropoietin receptors by Friend viral gp55 and by erythropoietin and down-modulation by the murine Fv-2r resistance gene. Proc. Natl. Acad. Sci. U S A 87:9985–9989.
Hoatlin, M. E., and Kabat, D. 1995. Host-range control of a retroviral disease: Friend erythroleukemia. Trends Microbiol. 3:51–57.
Horoszewicz, J. S., Leong, S. S., and Carter, W. A. 1975. Friend leukemia: rapid development of erythropoietin-independent hematopoietic precursors. J. Natl. Cancer Inst. 54:265–267.
Huff, J. L., Jelinek, M. A., Borgman, C. A., et al. 1993. The protooncogene c-sea encodes a transmembrane protein-tyrosine kinase related to the Met/hepatocyte growth factor/scatter factor receptor. Proc. Natl. Acad. Sci. U S A 90:6140–6144.
Huff, J. L., Jelinek, M. A., Jamieson, T. A., et al. 1996. Expression and maturation of the cellular sea receptor, a member of the hepatocyte growth factor (HGF) receptor family of protein tyrosine kinases. Oncogene 12:299–307.
Hull, S., and Fan, H. 2006. Mutational analysis of the cytoplasmic tail of jaagsiekte sheep retrovirus envelope protein. J. Virol. 80:8069–8080.
Hunter, T., and Sefton, B. M. 1980. Transforming gene product of Rous sarcoma virus phosphorylates tyrosine. Proc. Natl. Acad. Sci. U S A 77:1311–1315.
Ischenko, I., Petrenko, O., Gu, H., and Hayman, M. J. 2003. Scaffolding protein Gab2 mediates fibroblast transformation by the SEA tyrosine kinase. Oncogene 22:6311–6318.
Iwama, A., Okano, K., Sudo, T., et al. 1994. Molecular cloning of a novel receptor tyrosine kinase gene, STK, derived from enriched hematopoietic stem cells. Blood 83:3160–3169.
Jackson, P., and Baltimore, D. 1989. N-terminal mutations activate the leukemogenic potential of the myristoylated form of c-abl. EMBO J. 8:449–456.
Jelacic, T. M., Thompson, D., Hanson, C., et al. 2007. The tyrosine kinase Sf-Stk and its downstream signals are required for maintenance of friend spleen focus-forming virus-induced fibroblast transformation. J. Virol. XX:00–00.
Jia, R., Mayer, B. J., Hanafusa, T., et al. 1992. A novel oncogene, v-ryk, encoding a truncated receptor tyrosine kinase is transduced into the RPL30 virus without loss of viral sequences. J. Virol. 66:5975–5987.
Jia, R., and Hanafusa, H. 1994. The proto-oncogene of v-eyk (v-ryk) is a novel receptor-type protein tyrosine kinase with extracellular Ig/GN-III domains. J. Biol. Chem. 269:1839–1844.
Jiang, T., and Qiu, Y. 2003. Interaction between Src and a C-terminal proline-rich motif of Akt is required for Akt activation. J. Biol. Chem. 278:15789–15793.
Joazeiro, C. A., Wing, S. S., Huang, H., et al. 1999. The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase. Science 286:309–312.
Katz, E., Lareef, M. H., Rassa, J. C., et al. 2005. MMTV Env encodes an ITAM responsible for transformation of mammary epithelial cells in three-dimensional culture. J. Exp. Med. 201:431–439.
Kawai, S., Yoshida, M., Segawa, K., et al. 1980. Characterization of Y73, an avian sarcoma virus: a unique transforming gene and its product, a phosphopolyprotein with protein kinase activity. Proc. Natl. Acad. Sci. U S A 77:6199–6203.
Kirsten, W. H., and Meyer, L. A. 1967. Morphologic responses to a murine erythroblastosis virus. J. Natl. Cancer Inst. 39:311–335.
Klingmuller, U., Lorenz, U., Cantley, L. C., et al. 1995. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell 80:729–738.
Kloetzer, W. S., Maxwell, S. A., and Arlinghaus, R. B. 1983. P85gag-mos encoded by ts110 Moloney murine sarcoma virus has an associated protein kinase activity. Proc. Natl. Acad. Sci. U S A 80:412–416.
Klug, C. A., Gerety, S. J., Shah, P. C., et al. 1994. The v-abl tyrosine kinase negatively regulates NF-kappa B/Rel factors and blocks kappa gene transcription in pre-B lymphocytes. Genes Dev. 8:678–687.
Knight, J., Beug, H., Marshall, J., and Hayman, M. J. 1988. Abnormal glycosylation of the env-sea oncogene product inhibits its proteolytic cleavage and blocks its transforming ability. Oncogene 2:317–326.
Langdon, W. Y., Hartley, J. W., Klinken, et al. 1989. v-cbl, an oncogene from a dual-recombinant murine retrovirus that induces early B-lineage lymphomas. Proc. Natl. Acad. Sci. U S A 86:1168–1172.
Lavigueur, A., and Bernstein, A. 1991. p53 transgenic mice: accelerated erythroleukemia induction by Friend virus. Oncogene 6:2197–2201.
Lee, W. H., Bister, K., Pawson, A., et al. 1980. Fujinami sarcoma virus: an avian RNA tumor virus with a unique transforming gene. Proc. Natl. Acad. Sci. U S A 77:2018–2022.
Levine, R. L., and Gilliland, D. G. 2007. JAK-2 mutations and their relevance to myeloproliferative disease. Curr. Opin. Hematol. 14:43–47.
Li, J. P., Bestwick, R. K., Spiro, C., et al. 1987. The membrane glycoprotein of Friend spleen focus-forming virus: evidence that the cell surface component is required for pathogenesis and that it binds to a receptor. J. Virol. 61:2782–2792.
Li, J. P., D’Andrea, A. D., Lodish, H. F., and Baltimore, D. 1990. Activation of cell growth by binding of Friend spleen focus-forming virus gp55 glycoprotein to the erythropoietin receptor. Nature 343:762–764.
Liao, S. K., and Axelrad, A. A. 1975. Erythropoietin-independent erythroid colony formation in vitro by hemopoietic cells of mice infected with friend virus. Int. J. Cancer 15:467–482.
Liu, S. L., Duh, F. M., Lerman, M. I., et al. 2003. Role of virus receptor Hyal2 in oncogenic transformation of rodent fibroblasts by sheep betaretrovirus env proteins. J. Virol. 77:2850–2858.
Liu, S. L., Lerman, M. I., and Miller, A. D. 2003. Putative phosphatidylinositol 3-kinase (PI3K) binding motifs in ovine betaretrovirus Env proteins are not essential for rodent fibroblast transformation and PI3K/Akt activation. J. Virol. 77:7924–7935.
Liu, S. L., and Miller, A. D. 2005. Transformation of Madin-Darby canine kidney epithelial cells by sheep retrovirus envelope proteins. J. Virol. 79:927–933.
Liu, S. L., and Miller, A. D. 2007. Oncogenic transformation by the jaagsiekte sheep retrovirus envelope protein. Oncogene 26:789–801.
Livnah, O., Stura, E. A., Middleton, S. A., Johnson, D. L., Jolliffe, L. K., and Wilson, I. A. 1999. Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation. Science 283:987–990.
Maeda, N., Palmarini, M., Murgia, C., et al. 2001. Direct transformation of rodent fibroblasts by jaagsiekte sheep retrovirus DNA. Proc. Natl. Acad. Sci. U S A 98:4449–4454.
Maeda, N., Inoshima, Y., Fruman, D. A., et al. 2003. Transformation of mouse fibroblasts by jaagsiekte sheep retrovirus envelope does not require phosphatidylinositol 3-kinase. J. Virol. 77:9951–9959.
Maeda, N., Fu, W., Ortin, A., et al. 2005. Roles of the Ras-MEK-mitogen-activated protein kinase and phosphatidylinositol 3-kinase-Akt-mTOR pathways in jaagsiekte sheep retrovirus-induced transformation of rodent fibroblast and epithelial cell lines. J. Virol. 79:4440–4450.
Majumder, S., Ray, P., and Besmer, P. 1990. Tyrosine protein kinase activity of the HZ4-feline sarcoma virus P80gag-kit-transforming protein. Oncogene Res. 5:329–335.
Mathey-Prevot, B., Nabel, G., Palacios, R., et al. 1986. Abelson virus abrogation of interleukin-3 dependence in a lymphoid cell line. Mol. Cell Biol. 6:4133–4135.
Matsuda, M., Mayer, B. J., Fukui, Y., et al. 1990. Binding of transforming protein, p47gag-crk, to a broad range of phosphotyrosine-containing proteins. Science 248:1537–1539.
Matsushime, H., Wang, L. H., and Shibuya, M. 1986. Human c-ros-1 gene homologous to the v-ros sequence of UR2 sarcoma virus encodes for a transmembrane receptor-like molecule. Mol. Cell Biol. 6:3000–3004.
Mayer, B. J., Hamaguchi, M., and Hanafusa, H. 1988. A novel viral oncogene with structural similarity to phospholipase C. Nature 332:272–275.
Mayer, B. J., and Hanafusa, H. 1990. Association of the v-crk oncogene product with phosphotyrosine-containing proteins and protein-kinase activity. Proc. Natl. Acad. Sci. U S A 87:2638–2642.
McDonough, S. K., Larsen, S., Brodey, R. S., et al. 1971. A transmissible feline fibrosarcoma of viral origin. Cancer Res. 31:953–956.
Moelling, K., Heimann, B., Beimling, P., et al. 1984. Serine-specific and threonine-specific protein-kinase activities of purified gag-mil and gag-raf proteins. Nature 312:558–561.
Moloney, J. B. 1966. A virus-induced rhabdomyosarcoma of mice. Natl. Cancer Inst. Monogr. 22:139–142.
Moreau-Gachelin, F., Tavitian, A., and Tambourin, P. 1988. Spi-1 is a putative oncogene in virally induced murine erythroleukaemias. Nature 331:277–280.
Morimoto, A. M., and Hayman, M. J. 1994. Role of oligomerization of the S13 Env-Sea oncoprotein in cell transformation. J. Virol. 68:1837–1842.
Mostecki, J., Halgren, A., Radfar, A., et al. 2000. Loss of heterozygosity at the Ink4a/Arf locus facilitates Abelson virus transformation of pre-B cells. J. Virol. 74:9479–9487.
Mowat, M., Cheng, A., Kimura, N., et al. 1985. Rearrangements of the cellular p53 gene in erythroleukaemic cells transformed by Friend virus. Nature 314:633–636.
Munroe, D. G., Peacock, J. W., and Benchimol, S. 1990. Inactivation of the cellular p53 gene is a common feature of Friend virus-induced erythroleukemia: relationship of inactivation to dominant transforming alleles. Mol. Cell Biol. 10:3307–3313.
Muszynski, K. W., Ohashi, T., Hanson, C., et al. 1998. Both the polycythemia- and anemia-inducing strains of Friend spleen focus-forming virus induce constitutive activation of the Raf-1/mitogen-activated protein kinase signal transduction pathway. J. Virol. 72:919–925.
Muszynski, K. W., Thompson, D., Hanson, C., et al. 2000. Growth factor-independent proliferation of erythroid cells infected with Friend spleen focus-forming virus is protein kinase C dependent but does not require Ras-GTP. J. Virol. 74:8444–8451.
Naharro, G., Robbins, K. C., et al. 1984. Gene product of v-fgr onc: hybrid protein containing a portion of actin and a tyrosine-specific protein kinase. Science 223:63–66.
Nepveu, A., Fahrlander, P. D., Yang, J. Q., et al. 1985. Amplification and altered expression of the c-myc oncogene in A-MuLV-transformed fibroblasts. Nature 317:440–443.
Ni, S., Zhao, C., Feng, G. S., et al. 2007. A novel Stat3 binding motif in Gab2 mediates transformation of primary hematopoietic cells by the Stk/Ron receptor tyrosine kinase in response to Friend virus infection. Mol. Cell Biol. 27:3708–3715.
Nishigaki, K., Hanson, C., Ohashi, T., et al. 2000. Erythroid cells rendered erythropoietin independent by infection with Friend spleen focus-forming virus show constitutive activation of phosphatidylinositol 3-kinase and Akt kinase: involvement of insulin receptor substrate-related adapter proteins. J. Virol. 74:3037–3045.
Nishigaki, K., Thompson, D., Hanson, C., et al. 2001. The envelope glycoprotein of friend spleen focus-forming virus covalently interacts with and constitutively activates a truncated form of the receptor tyrosine kinase Stk. J. Virol. 75:7893–7903.
Nishigaki, K., Hanson, C., Jelacic, T., et al. 2005a. Friend spleen focus-forming virus transforms rodent fibroblasts in cooperation with a short form of the receptor tyrosine kinase Stk. Proc. Natl. Acad. Sci. U S A 102:15488–15493.
Nishigaki, K., Hanson, C., Thompson, D., et al. 2005b. Activation of the Jun N-terminal kinase pathway by Friend spleen focus-forming virus and its role in the growth and survival of Friend virus-induced erythroleukemia cells. J. Virol. 79:12752–12762.
Nishigaki, K., Hanson, C., Ohashi, T., et al. 2006. Erythroblast transformation by the friend spleen focus-forming virus is associated with a block in erythropoietin-induced STAT1 phosphorylation and DNA binding and correlates with high expression of the hematopoietic phosphatase SHP-1. J. Virol. 80:5678–5685.
Noronha, E. J., Sterling, K. H., et al. 2003. Increased expression of Bcl-xL and c-Myc is associated with transformation by Abelson murine leukemia virus. J. Biol. Chem. 278:50915–50922.
Ohashi, T., Masuda, M., and Ruscetti, S. K. 1995. Induction of sequence-specific DNA-binding factors by erythropoietin and the spleen focus-forming virus. Blood 85:1454–1462.
Ohashi, T., Masuda, M., and Ruscetti, S. K. 1997. Constitutive activation of Stat-related DNA-binding proteins in erythroid cells by the Friend spleen focus-forming virus. Leukemia 11:251–254.
Owen, P. J., Musk, P., Evans, C. A., et al. 1993. Cellular signaling events elicited by v-abl associated with growth factor independence in an interleukin-3-dependent cell line. J. Biol. Chem. 268:15696–15703.
Palmarini, M., Datta, S., Omid, R., et al. 2000. The long terminal repeat of jaagsiekte sheep retrovirus is preferentially active in differentiated epithelial cells of the lungs. J. Virol. 74:5776–5787.
Palmarini, M., and Fan, H. 2001. Retrovirus-induced ovine pulmonary adenocarcinoma, an animal model for lung cancer. J. Natl. Cancer Inst. 93:1603–1614.
Palmarini, M., Maeda, N., Murgia, C., et al. 2001. A phosphatidylinositol 3-kinase docking site in the cytoplasmic tail of the jaagsiekte sheep retrovirus transmembrane protein is essential for envelope-induced transformation of NIH 3T3 cells. J. Virol. 75:11002–11009.
Park, C. Y., and Hayman, M. J. 1999. The tyrosines in the bidentate motif of the env-sea oncoprotein are essential for cell transformation and are binding sites for Grb2 and the tyrosine phosphatase SHP-2. J. Biol. Chem. 274:7583–7590.
Parmar, K., and Rosenberg, N. 1996. Ras complements the carboxyl terminus of v-Abl protein in lymphoid transformation. J. Virol. 70:1009–1015.
Paul, R., Schuetze, S., Kozak, S. L., et al. 1989. A common site for immortalizing proviral integrations in Friend erythroleukemia: molecular cloning and characterization. J. Virol. 63:4958–4961.
Paul, R., Schuetze, S., Kozak, S. L., et al. 1991. The Sfpi-1 proviral integration site of Friend erythroleukemia encodes the ets-related transcription factor Pu.1. J. Virol. 65:464–467.
Persons, D. A., Paulson, R. F., Loyd, M. R., et al. 1999. Fv2 encodes a truncated form of the Stk receptor tyrosine kinase. Nat. Genet. 23:159–165.
Pierce, J. H., Di Fiore, P. P., Aaronson, S. A., et al. 1985. Neoplastic transformation of mast cells by Abelson-MuLV: abrogation of IL-3 dependence by a nonautocrine mechanism. Cell 41:685–693.
Prasher, J. M., Elenitoba-Johnson, K. S., and Kelley, L. L. 2001. Loss of p53 tumor suppressor function is required for in vivo progression of Friend erythroleukemia. Oncogene 20:2946–2955.
Premkumar, E., Potter, M., Singer, P. A., et al. 1975. Synthesis, surface deposition, and secretion of immunoglobulins by Abelson virus-transformed lymphosarcoma cell lines. Cell 6:149–159.
Prywes, R., Foulkes, J. G., Rosenberg, N., et al. 1983. Sequences of the A-MuLV protein needed for fibroblast and lymphoid cell transformation. Cell 34:569–579.
Prywes, R., Foulkes, J. G., and Baltimore, D. 1985. The minimum transforming region of v-abl is the segment encoding protein-tyrosine kinase. J. Virol. 54:114–122.
Prywes, R., Hoag, J., Rosenberg, N., et al. 1985. Protein stabilization explains the gag requirement for transformation of lymphoid cells by Abelson murine leukemia virus. J. Virol. 54:123–132.
Qiu, F., Ray, P., Brown, K., et al. 1988. Primary structure of c-kit: Relationship with the CSF-1/PDGF receptor kinase family--Oncogenic activation of v-kit involves deletion of extracellular domain and C-terminus. EMBO J. 7:1003–1011.
Rabstein, L. S., Gazdar, A. F., Chopra, H. C., et al. 1971. Early morphological changes associated with infection by a murine nonthymic lymphatic tumor virus. J. Natl. Cancer Inst. 46:481–491.
Radfar, A., Unnikrishnan, I., Lee, H. W., et al. 1998. p19(Arf) induces p53-dependent apoptosis during abelson virus-mediated pre-B cell transformation. Proc. Natl. Acad. Sci. U S A 95:13194–13199.
Raffel, G. D., Parmar, K., and Rosenberg, N. 1996. In vivo association of v-Abl with Shc mediated by a non-phosphotyrosine-dependent SH2 interaction. J. Biol. Chem. 271:4640–4645.
Rai, S. K., Duh, F. M., Vigdorovich, V., et al. 2001. Candidate tumor suppressor HYAL2 is a glycosylphosphatidylinositol (GPI)-anchored cell-surface receptor for jaagsiekte sheep retrovirus, the envelope protein of which mediates oncogenic transformation. Proc. Natl. Acad. Sci. U S A 98:4443–4448.
Rapp, U. R., Goldsborough, M. D., Mark, G. E., et al. 1983. Structure and biological-activity of v-raf, a unique oncogene transduced by a retrovirus. Proc. Natl. Acad. Sci. U S A 80:4218–4222.
Rapp, U. R., Reynolds, F. H., Jr., and Stephenson, J. R. 1983. New mammalian transforming retrovirus: demonstration of a polyprotein gene product. J. Virol. 45:914–924.
Reddy, E. P., Smith, M. J., and Srinivasan, A. 1983. Nucleotide sequence of Abelson murine leukemia virus genome: structural similarity of its transforming gene product to other onc gene products with tyrosine-specific kinase activity. Proc. Natl. Acad. Sci. U S A 80:3623–3627.
Remy, I., Wilson, I. A., and Michnick, S. W. 1999. Erythropoietin receptor activation by a ligand-induced conformation change. Science 283:990–993.
Ren, R., Ye, Z. S., and Baltimore, D. 1994. Abl protein-tyrosine kinase selects the Crk adapter as a substrate using SH3-binding sites. Genes Dev. 8:783–795.
Renshaw, M. W., Lea-Chou, E., and Wang, J. Y. 1996. Rac is required for v-Abl tyrosine kinase to activate mitogenesis. Curr. Biol. 6:76–83.
Richmond, T. D., Chohan, M., and Barber, D. L. 2005. Turning cells red: signal transduction mediated by erythropoietin. Trends Cell Biol. 15:146–155.
Rosenberg, N., Baltimore, D., and Scher, C. D. 1975. In vitro transformation of lymphoid cells by Abelson murine leukemia virus. Proc. Natl. Acad. Sci. U S A 72:1932–1936.
Rosenberg, N., and Baltimore, D. 1976. A quantitative assay for transformation of bone marrow cells by Abelson murine leukemia virus. J. Exp. Med. 143:1453–1463.
Rosenberg, N., and Witte, O. N. 1980. Abelson murine leukemia virus mutants with alterations in the virus-specific P120 molecule. J. Virol. 33:340–348.
Rosenberg, N. E., Clark, D. R., and Witte, O. N. 1980. Abelson murine leukemia virus mutants deficient in kinase activity and lymphoid cell transformation. J. Virol. 36:766–774.
Rous, P. 1911. A sarcoma of the fowl transmissible by an agent separable from the tumor cells. J. Exp. Med. 13:397–411.
Roussel, M., Saule, S., Lagrou, C., et al. 1979. Three new types of viral oncogene of cellular origin specific for haematopoietic cell transformation. Nature 281:452–455.
Roussel, M. F., Downing, J. R., Rettenmier, C. W., et al. 1988. A point mutation in the extracellular domain of the human CSF-1 Receptor (c-fms proto-oncogene product) activates its transforming potential. Cell 55:979–988.
Rovera, G., Valtieri, M., Mavilio, F., and Reddy, E. P. 1987. Effect of Abelson murine leukemia virus on granulocytic differentiation and interleukin-3 dependence of a murine progenitor cell line. Oncogene 1:29–35.
Rulli, K., Yugawa, T., Hanson, C., et al. 2004. Ex vivo and in vivo biological effects of a truncated form of the receptor tyrosine kinase Stk when activated by interaction with the friend spleen focus-forming virus envelope glycoprotein or by point mutation. J. Virol. 78:4573–4581.
Ruscetti, S. K., Linemeyer, D., Feild, J., et al. 1979. Characterization of a protein found in cells infected with the spleen focus-forming virus that shares immunological cross-reactivity with the gp70 found in mink cell focus-inducing virus particles. J. Virol. 30:787–798.
Ruscetti, S. K., Janesch, N. J., and Chakraborti A. 1990. Friend spleen focus-forming virus induces factor independence in an erythropoietin-dependent erythroleukemia cell line. J. Virol. 64:1057–1062.
Ruscetti, S. K. 1999. Deregulation of erythropoiesis by the Friend spleen focus-forming virus. Int. J. Biochem. Cell Biol. 31:1089–1109.
Ruta, M., Clarke, S., Boswell, B., et al. 1982. Heterogeneous metabolism and subcellular localization of a potentially leukemogenic membrane glycoprotein encoded by Friend erythroleukemia virus. Isolation of viral and cellular processing mutants. J. Biol. Chem. 257:126–134.
Ruta, M., Bestwick, R., Machida, C., et al. 1983. Loss of leukemogenicity caused by mutations in the membrane glycoprotein structural gene of Friend spleen focus-forming virus. Proc. Natl. Acad. Sci. U S A 80:4704–4708.
Sachs, Z., Sharpless, N. E., DePinho, R. A., et al. 2004. p16(Ink4a) interferes with Abelson virus transformation by enhancing apoptosis. J. Virol. 78:3304–3311.
Sawyers, C. L., Callahan, W., and Witte, O. N. 1992. Dominant negative MYC blocks transformation by ABL oncogenes. Cell 70:901–910.
Sawyers, C. L., McLaughlin, J., and Witte, O. N. 1995. Genetic requirement for Ras in the transformation of fibroblasts and hematopoietic cells by the Bcr-Abl oncogene. J. Exp. Med. 181:307–313.
Scher, C. D., and Siegler, R. 1975. Direct transformation of 3T3 cells by Abelson murine leukaemia virus. Nature 253:729–731.
Schlessinger, J. 2000. Cell signaling by receptor tyrosine kinases. Cell 103:211–225.
Schubbert, S., Shannon, K., and Bollag, G. 2007. Hyperactive Ras in developmental disorders and cancer. Nat. Rev. Cancer 7:295–308.
Schuetze, S., Paul, R., Gliniak, B. C., et al. 1992. Role of the PU.1 transcription factor in controlling differentiation of Friend erythroleukemia cells. Mol. Cell Biol. 12:2967–2975.
Schultz, A., and Oroszlan, S. 1984. Myristylation of gag-onc fusion proteins in mammalian transforming retroviruses. Virology 133:431–437.
Scolnick, E. M., and Parks, W. P. 1974. Harvey sarcoma virus: a second murine type C sarcoma virus with rat genetic information. J. Virol. 13:1211–1219.
Scolnick, E. M., Goldberg, R. J., and Williams, D. 1976. Characterizatiion of rat genetic sequences of Kirsten sarcoma virus: distinct class of endogenous rat type C viral sequences. J. Virol. 18:559–566.
Scolnick, E. M., Papageorge, A. G., Shih, T. Y. 1979. Guanine nucleotide-binding activity as an assay for src protein of rat-derived murine sarcoma viruses. Proc. Natl. Acad. Sci. U S A 76:5355–5359.
Sexl, V., Piekorz, R., Moriggl, R., et al. 2000. Stat5a/b contribute to interleukin 7-induced B-cell precursor expansion, but abl- and bcr/abl-induced transformation are independent of stat5. Blood 96:2277–2283.
Sharp, J. M., and DeMartini, J. C. 2003. Natural history of JSRV in sheep. Curr. Top. Microbiol. Immunol. 275:55–79.
Shibuya, M., Hanafusa, T., Hanafusa, H., et al. 1980. Homology exists among the transforming sequences of avian and feline sarcoma viruses. Proc. Natl. Acad. Sci. U S A 77:6536–6540.
Shore, S. K., Tantravahi, R. V., and Reddy, E. P. 2002. Transforming pathways activated by the v-Abl tyrosine kinase. Oncogene 21:8568–8576.
Siden, E. J., Baltimore, D., Clark, D., et al. 1979. Immunoglobulin synthesis by lymphoid cells transformed in vitro by Abelson murine leukemia virus. Cell 16:389–396.
Siegler, R., and Zajdel, S. 1972. Pathogenesis of Abelson-virus-induced murine leukemia. J. Natl. Cancer Inst. 48:189–218.
Singh, B., and Arlinghaus, R. B. 1997. Mos and the cell cycle. Prog. Cell Cycle Res. 3:251–259.
Smith, D. R., Vogt, P. K., and Hayman, M. J. 1989. The v-sea oncogene of avian erythroblastosis retrovirus S13: another member of the protein-tyrosine kinase gene family. Proc. Natl. Acad. Sci. U S A 86:5291–5295.
Smith, M. R., DeGudicibus, S. J., and Stacey, D. W. 1986. Requirement for c-ras proteins during viral oncogene transformation. Nature 320:540–543.
Snyder, S. P., and Theilen, G. H. 1969. Transmissible feline fibrosarcoma. Nature 221:1074–1075.
Socolovsky, M., Fallon, A. E., Wang, S., et al. 1999. Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/- mice: a direct role for Stat5 in Bcl-XL induction. Cell 98:181–191.
Songyang, Z., Shoelson, S. E., Chaudhuri, M., et al. 1993. SH2 domains recognize specific phosphopeptide sequences. Cell 72:767–778.
Songyang, Z., Shoelson, S. E., McGlade, J., et al. 1994. Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav. Mol. Cell Biol. 14:2777–2785.
Souyri, M., Vigon, I., Penciolelli, J. F., et al. 1990. A putative truncated cytokine receptor gene transduced by the myeloproliferative leukemia virus immortalizes hematopoietic progenitors. Cell 63:1137–1147.
Srinivas, R. V., and Compans, R. W. 1983. Membrane association and defective transport of spleen focus-forming virus glycoproteins. J. Biol. Chem. 258:14718–14724.
Srinivas, R. V., Kilpatrick, D. R., Tucker, S., et al. 1991. The hydrophobic membrane-spanning sequences of the gp52 glycoprotein are required for the pathogenicity of Friend spleen focus-forming virus. J. Virol. 65:5272–5280.
Srinivasan, A., Reddy, E. P., and Aaronson, S. A. 1981. Abelson murine leukemia virus: molecular cloning of infectious integrated proviral DNA. Proc. Natl. Acad. Sci. U S A 78:2077–2081.
Srinivasan, A., Dunn, C. Y., Yuasa, Y., et al. 1982. Abelson murine leukemia virus: structural requirements for transforming gene function. Proc. Natl. Acad. Sci. U S A 79:5508–5512.
Staal, S. P., Hartley, J. W., and Rowe, W. P. 1977. Isolation of transforming murine leukemia viruses from mice with a high incidence of spontaneous lymphoma. Proc. Natl. Acad. Sci. U S A 74:3065–3067.
Stacey, D. W., Roudebush, M., Day, R., et al. 1991. Dominant inhibitory Ras mutants demonstrate the requirement for Ras activity in the action of tyrosine kinase oncogenes. Oncogene 6:2297–2304.
Steinheider, G., Seidel, H. J., et al. 1979. Comparison of the biological effects of anemia inducing and polycythemia inducing Friend virus complex. Experientia 35:1173–1175.
Suau, F., Cottin, V., Archer, F., et al. 2006. Telomerase activation in a model of lung adenocarcinoma. Eur. Respir. J. 27:1175–1182.
Subramanian, A., Hegde, S., Correll, P. H., et al. 2006. Mutation of the Lyn tyrosine kinase delays the progression of Friend virus induced erythroleukemia without affecting susceptibility. Leuk. Res. 30:1141–1149.
Tambourin, P. E., Wendling, F., Jasmin, C., et al. 1979. The physiopathology of Friend leukemia. Leuk. Res. 3:117–129.
Tanaka, M., Gupta, R., et al. 1995. Differential inhibition of signaling pathways by dominant-negative SH2/SH3 adapter proteins. Mol. Cell Biol. 15:6829–6837.
Tang, X., Downes, C. P., Whetton, A. D., et al. 2000. Role of phosphatidylinositol 3-kinase and specific protein kinase B isoforms in the suppression of apoptosis mediated by the Abelson protein-tyrosine kinase. J. Biol. Chem. 275:13142–13148.
Teal, H. E., Ni, S., Xu, J., et al. 2006. GRB2-mediated recruitment of GAB2, but not GAB1, to SF-STK supports the expansion of Friend virus-infected erythroid progenitor cells. Oncogene 25:2433–2443.
Thome, K. C., Radfar, A., and Rosenberg, N. 1997. Mutation of Tp53 contributes to the malignant phenotype of Abelson virus-transformed lymphoid cells. J. Virol. 71:8149–8156.
Troxler, D. H., Parks, W. P., Vass, W. C., et al. 1977. Isolation of a fibroblast nonproducer cell line containing the Friend strain of the spleen focus-forming virus. Virology 76:602–615.
Tsushima, H., Urata, Y., Miyazaki, Y., et al. 1997. Human erythropoietin receptor increases GATA-2 and Bcl-xL by a protein kinase C-dependent pathway in human erythropoietin-dependent cell line AS-E2. Cell Growth Differ. 8:1317–1328.
Turner, S. D., and Alexander, D. R. 2006. Fusion tyrosine kinase mediated signalling pathways in the transformation of haematopoietic cells. Leukemia 20:572–582.
Unnikrishnan, I., Radfar, A., Jenab-Wolcott, J., et al. 1999. p53 mediates apoptotic crisis in primary Abelson virus-transformed pre-B cells. Mol. Cell Biol. 19:4825–4831.
Unnikrishnan I Rosenberg, N. 2003. Absence of p53 complements defects in Abelson murine leukemia virus signaling. J. Virol. 77:6208–6215.
Van de Ven, W. J., Reynolds, F. H., Jr., and Stephenson, J. R. 1980. The nonstructural components of polyproteins encoded by replication-defective mammalian transforming retroviruses are phosphorylated and have associated protein kinase activity. Virology 101:185–197.
Varela, M., Chow, Y. H., Sturkie, C., et al. 2006. Association of RON tyrosine kinase with the Jaagsiekte sheep retrovirus envelope glycoprotein. Virology 350::347–357.
Varticovski, L., Daley, G. Q., Jackson, P., et al. 1991. Activation of phosphatidylinositol 3-kinase in cells expressing abl oncogene variants. Mol. Cell Biol. 11:1107–1113.
Verwoerd, D. W., Payne, A. L., York, D. F., et al. 1983. Isolation and preliminary characterization of the jaagsiekte retrovirus (JSRV). Onderstepoort J. Vet. Res. 50:309–316.
Wahl, R. C., Hsu, R. Y., Huff, J. L., et al. 1999. Chicken macrophage stimulating protein is a ligand of the receptor protein-tyrosine kinase Sea. J. Biol. Chem. 274:26361–26368.
Wang, L. H., Feldman, R., Shibuya, M., et al. 1981. Genetic structure, transforming sequence, and gene product of avian sarcoma virus UR1. J. Virol. 40:258–267.
Wang, M. H., Iwama, A., Skeel, A., et al. 1995. The murine stk gene product, a transmembrane protein tyrosine kinase, is a receptor for macrophage-stimulating protein. Proc. Natl. Acad. Sci. U S A 92:3933–3937.
Warren, D., Heilpern, A. J., Berg, K., et al. 2000. The carboxyl terminus of v-Abl protein can augment SH2 domain function. J. Virol. 74:4495–4504.
Warren, D., Griffin, D. S., Mainville, C., et al. 2003. The extreme carboxyl terminus of v-Abl is required for lymphoid cell transformation by Abelson virus. J. Virol. 77:4617–4625.
Watanabe, N., Nishi, M., Ikawa, Y., et al. 1990. A deletion in the Friend spleen focus-forming virus env gene is necessary for its product (gp55) to be leukemogenic. J. Virol. 64:2678–2686.
Watanabe, N., Yugawa, T., Ikawa, Y., et al. 1995. Both the changes of six amino acids and the C-terminal truncation caused by a one-base insertion in the defective env gene of Friend spleen focus-forming virus significantly affect the pathogenic activity of the encoded leukemogenic membrane glycoprotein (gp55). J. Virol. 69:7606–7611.
Waterfield, M. D., Scrace, G. T., Whittle, N., et al. 1983. Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of Simian sarcoma virus. Nature 304:35–39.
Weissinger, E. M., Eissner, G., Grammer, C., et al. 1997. Inhibition of the Raf-1 kinase by cyclic AMP agonists causes apoptosis of v-abl-transformed cells. Mol. Cell Biol. 17:3229–3241.
Wendling, F., Varlet, P., Charon, M., et al. 1986. MPLV: a retrovirus complex inducing an acute myeloproliferative leukemic disorder in adult mice. Virology 149:242–246.
Whitlock, C. A., and Witte, O. N. 1981. Abelson virus-infected cells can exhibit restricted in vitro growth and low oncogenic potential. J. Virol. 40:577–584.
Whitlock, C. A., Ziegler, S. F., and Witte, O. N. 1983. Progression of the transformed phenotype in clonal lines of Abelson virus-infected lymphocytes. Mol. Cell Biol. 3:596–604.
Witte, O. N., Rosenberg, N., Paskind, M., et al. 1978. Identification of an Abelson murine leukemia virus-encoded protein present in transformed fibroblast and lymphoid cells. Proc. Natl. Acad. Sci. U S A 75:2488–2492.
Witte, O. N., Dasgupta, A., and Baltimore, D. 1980. Abelson murine leukaemia virus protein is phosphorylated in vitro to form phosphotyrosine. Nature 283:826–831.
Witte, O. N., Sun, L., Rosenberg, N., and Baltimore, D. 1980. A trans-acting protein kinase identified in cells transformed by Abelson murine leukemia virus. Cold Spring Harb. Symp. Quant. Biol. 44(Pt 2):855–857.
Witthuhn, B. A., Quelle, F. W., Silvennoinen, O., et al. 1993. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 74:227–236.
Wolff, L., Deinhardt, G. H., Theilen, G. H., et al. 1971. Induction of tumors in marmoset monkeys by simian sarcoma virus, type I (Lagothrix): A preliminary report. J. Natl. Cancer Inst. 47:1115–1120.
Wolff, L., Scolnick, E., and Ruscetti, S. 1983. Envelope gene of the Friend spleen focus-forming virus: deletion and insertions in 3 gp70/p15E-encoding region have resulted in unique features in the primary structure of its protein product. Proc. Natl. Acad. Sci. U S A 80:4718–4722.
Wolff, L., Kaminchik, J., Hankins, W. D., et al. 1985. Sequence comparisons of the anemia- and polycythemia-inducing strains of Friend spleen focus-forming virus. J. Virol. 53:570–578.
Wolff, L., and Ruscetti, S. 1988. The spleen focus-forming virus (SFFV) envelope gene, when introduced into mice in the absence of other SFFV genes, induces acute erythroleukemia. J. Virol. 62:2158–2163.
Woolford, J., A, M. c. a. u. l. i. f. f. e., and Rohrschneider, L. R. 1988. Activation of the feline c-fms proto-oncogene: Multiple alterations are required to generate a fully transformed phenotype. Cell 55:965–977.
Wootton, S. K., Halbert, C. L., and Miller, A. D. 2005. Sheep retrovirus structural protein induces lung tumours. Nature 434:904–907.
Wootton, S. K., Metzger, M. J., Hudkins, K. L., et al. 2006. Lung cancer induced in mice by the envelope protein of jaagsiekte sheep retrovirus (JSRV) closely resembles lung cancer in sheep infected with JSRV. Retrovirology 3:94.
Yamamoto, T., Hihara, H., Nishida, T., Kawai, S., et al. 1983. A new avian erythroblastosis virus, AEV-H, carries erbB gene responsible for the induction of both erythroblastosis and sarcomas. Cell 34:225–232.
Yi, C. R., and Rosenberg, N. 2007. Gag influences transformation by Abelson murine leukemia virus and suppresses nuclear localization of the v-Abl protein. J. Virol. 81:9461–9468.
Zang, H., Sato, K., Nakajima, H., et al. 2001. The distal region and receptor tyrosines of the Epo receptor are non-essential for in vivo erythropoiesis. EMBO J. 20:3156–3166.
Zavala, G., Pretto, C., Chow, Y. H., et al. 2003. Relevance of Akt phosphorylation in cell transformation induced by Jaagsiekte sheep retrovirus. Virology 312:95–105.
Zhang, J., Randall, M. S., Loyd, M. R., et al. 2006. Role of erythropoietin receptor signaling in Friend virus-induced erythroblastosis and polycythemia. Blood 107:73–78.
Ziemiecki, A., Hennig, D., Gardner, L., et al. 1984. Biological and biochemical characterization of a new isolate of feline sarcoma virus: Theilen-Pedersen (TP1-FeSV). Virology 138:324–331.
Zou, X., Rudchenko, S., Wong K., et al. 1997. Induction of c-myc transcription by the v-Abl tyrosine kinase requires Ras, Raf1, and cyclin-dependent kinases. Genes Dev. 11:654–662.
Zou, X., and Calame, K. 1999. Signaling pathways activated by oncogenic forms of Abl tyrosine kinase. J. Biol. Chem. 274:18141–18144.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Ruscetti, S.K., Cmarik, J.L. (2010). Deregulation of Signal Transduction Pathways by Oncogenic Retroviruses. In: Dudley, J. (eds) Retroviruses and Insights into Cancer. Springer, New York, NY. https://doi.org/10.1007/978-0-387-09581-3_3
Download citation
DOI: https://doi.org/10.1007/978-0-387-09581-3_3
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-09580-6
Online ISBN: 978-0-387-09581-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)